Treatment for HPV-positive oropharyngeal cancer varies by facility type

DALLAS — Treatment modality for HPV-positive oropharyngeal squamous cell carcinoma varied considerably by facility type, according to study results.
The findings — presented at American Head & Neck Society Annual Meeting — showed academic hospitals more frequently utilized surgery instead of radiation therapy or chemoradiation therapy alone as the primary treatment modality for early- and late-stage cancers.
The findings suggest a lack of standardized treatment regimens that prevent patients from receiving universal care independent of facility resources, Monica S. Trent,

DALLAS — Treatment modality for HPV-positive oropharyngeal squamous cell carcinoma varied considerably by facility type, according to study results.
The findings — presented at American Head & Neck Society Annual Meeting — showed academic hospitals more frequently utilized surgery instead of radiation therapy or chemoradiation therapy alone as the primary treatment modality for early- and late-stage cancers.
The findings suggest a lack of standardized treatment regimens that prevent patients from receiving universal care independent of facility resources, Monica S. Trent,